Cleveland Diabetes Care
Curated by SignalDeveloper of treatment solutions for diabetes, endocrinology and metabolic diseases
Overview
Cleveland Diabetes Care has developed gene therapy and medical devices to treat diabetes, endocrinology and metabolic diseases. The company has developed MetLite, a formulation of metformin made using potassium, to treat type II diabetes. The company claims that the product showed lower gastrointestinal side effects than metformin. It also offers a connected device, consisting of sensors, is attached to the arm to monitor glucose levels which are tracked by the companion app to analyze the glucose trends.
Key facts
- Founded
- 2009
- Headquarters
- Jacksonville, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Contact
- Sign up to view
- Phone
- Sign up to view